DOK2 is also associated with colorectal cancer (Wen et al., 2015), lung cancer (Berger et al., 2013; Chen et al., 2019), and renal cancer (Kužma et al., 2019; Solarek et al., 2019). Here, DOK2 is linked to lung carcinoma.